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Abstract 
Background: Tools for shared decision-making (e.g. decision aids) are intended to support health care profession-
als and patients engaged in clinical encounters involving shared decision-making. However, decision aids are hard 
to produce, and onerous to update. Consequently, they often do not reflect best current evidence, and show limited 
uptake in practice. In response, we initiated the Sharing Evidence to Inform Treatment decisions (SHARE-IT) project. 
Our goal was to develop and refine a new generation of decision aids that are generically produced along digitally 
structured guidelines and evidence summaries.
Methods: Applying principles of human-centred design and following the International Patient Decision Aid Stand-
ards (IPDAS) and GRADE methods for trustworthy evidence summaries we developed a decision aid prototype in col-
laboration with the Developing and Evaluating Communication strategies to support Informed Decisions and prac-
tice based on Evidence project (DECIDE). We iteratively user-tested the prototype in clinical consultations between 
clinicians and patients. Semi-structured interviews of participating clinicians and patients were conducted. Qualitative 
content analysis of both user-testing sessions and interviews was performed and results categorized according to a 
revised Morville’s framework of user-experience. We made it possible to produce, publish and use these decision aids 
in an electronic guideline authoring and publication platform (MAGICapp).
Results: Direct observations and analysis of user-testing of 28 clinical consultations between physicians and patients 
informed four major iterations that addressed readability, understandability, usability and ways to cope with informa-
tion overload. Participants reported that the tool supported natural flow of the conversation and induced a positive 
shift in consultation habits towards shared decision-making. We integrated the functionality of SHARE-IT decision aids 
in MAGICapp, which has since generated numerous decision aids.
Conclusion: Our study provides a proof of concept that encounter decision aids can be generically produced from 
GRADE evidence summaries and clinical guidelines. Online authoring and publication platforms can help scale up 
production including continuous updating of electronic encounter decision aids, fully integrated with evidence sum-
maries and clinical practice guidelines.
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Background
Most medical decisions are highly context-dependant, 
and, when creating individual plans of care, current 
best evidence of potential benefits and harms requires 
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interpretation in light of patients’ values and preferences. 
Shared decision-making is the process in which patients 
and clinicians partner together and have a conversation 
to find the best option for that patient [1]. Communicat-
ing evidence for shared decision-making is challenging 
[2]. Trustworthy clinical practice guidelines (henceforth 
guidelines) are amongst the most reliable methods of 
translating evidence into statements to guide practice, 
but are typically not designed to support shared decision-
making. Decision aids represent widely advocated tools 
for shared decision-making [3]. Decision aids improve 
patients’ knowledge of options, their perception of feel-
ing well-informed, and their clarity regarding what mat-
ters most to them [3].
Both guidelines and decision aids face similar chal-
lenges: their production and updating is highly resource-
demanding, they are often not based on best available 
evidence, they may be hard to find and use, and their 
uptake is highly variable in practice [4]. We have pre-
viously reported how we have addressed these over-
arching challenges in the Sharing Evidence to Inform 
Treatment decisions (SHARE-IT) project [4]. SHARE-IT 
has resulted in a new generation of generic decision aids 
linked to trustworthy guidelines and evidence summaries 
in digitally structured formats [4, 5]. These encounter 
decision aids are designed to be used by clinicians and 
patients to explore together the management options and 
facilitate shared decision-making [4].
We report here our detailed approach to SHARE-IT 
encounter decision aids conceptual and technical devel-
opment, and results from iterative user-testing to achieve 
user-friendly presentation formats. We also report how 
these encounter decision aids were integrated in MAGI-
Capp, a digital authoring and publication platform for 
guidelines and evidence summaries. In MAGICapp, the 
evidence data is structured in a way that enables a semi-
automated production of decision aids, and facilitate dis-
semination and dynamic updating of them, within the 
context of guidelines [4].
Methods
Overview and rationale
SHARE-IT was initiated in 2012 by the non-profit 
MAGIC Evidence Ecosystem Foundation [6]. Combin-
ing research with innovation and product development 
within a digital and trustworthy evidence ecosystem, 
MAGIC aims to provide clinicians and patients with 
user-friendly tools for decision support implemented at 
the point of care [4, 5]. Its online authoring and publi-
cation platform—the MAGICapp (Fig.  1)—was initially 
developed to apply GRADE methodology (Grading of 
Recommendations Assessment, Development and Eval-
uation) [7] to author, publish and dynamically update 
trustworthy guidelines in user-friendly formats [5]. We 
quickly identified the need to translate digitally struc-
tured data into tools that could support shared decision-
making in the clinical encounter.
We conceived SHARE-IT in collaboration with the 
DECIDE project (Developing and Evaluating Commu-
nication strategies to support Informed Decisions and 
practice based on Evidence), a multi-national research 
project initiated by the GRADE working group and 
funded by the European Union [8–11]. After the DECIDE 
project ended in 2014, our team continued user-testing 
and developing the decision aids. A major consequent 
refinement was the addition of a display of practical 
issues to complement evidence on benefits and harms 
[12, 13].
Based on initial feedback from experts and stakehold-
ers, principles of human-centred design were applied, 
and led to iterative revisions of the encounter decision 
aids through repeated observations with patients and 
clinicians engaged in real-life decision-making [14]. Fig-
ure  2 shows the three phases of our project, as defined 
in DECIDE: (1) brainstorming and stakeholder feedback 
with a multidisciplinary team to develop a conceptual 
framework and prototype decision aid; (2) iterative devel-
opment and user testing of the decision aids; (3) their 
generic semi-automated production, from GRADE evi-
dence summaries linked to guidelines, in MAGICapp.
Development of the decision aids
Sketching the initial template
We based our initial prototype on evidence regarding 
optimal formats for shared decision-making, with a par-
ticular focus on encounter decision aids. In particular, 
our template was inspired by decision aid cards centred 
on key outcomes and issues meaningful to patients pio-
neered by Dr. Montori and his team in the Mayo Clinic 
Knowledge and Evaluation Research Unit [15].
Our team combining expertise in GRADE method-
ology, shared decision-making and human-centered 
design, built several prototypes with the help of an inter-
action designer (FA). We followed a modified “mobile 
first” approach [16] in sketching and creating the initial 
template, using an online calculator [17] and Blueprint 
software [18] which allowed us to quickly customize and 
test our prototypes on tablet screens. We judged use 
of the tool on a desktop computer would not optimally 
facilitate face to face communication between patient 
and clinician in clinical encounters.
Stakeholder feedback and brainstorming on the next 
iterations
To move from the initial template to a conceptual frame-
work and prototype decision aids linked to guidelines, we 
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conducted three face-to-face meetings with stakeholders 
in DECIDE (Canada 2012, Italy 2013, and Peru 2013) [8]. 
The meetings involved clinicians and experts in shared 
decision-making, guideline development and designers. 
The experts evaluated the initial template and subsequent 
prototype decision aids and participated in brainstorm-
ing, discussion and feedback.
User testing
Following stakeholder feedback, the team prepared the 
prototype for formal user testing in clinical encounters 
to learn about the design from a user’s perspective to 
improve its next iteration as opposed to developers or 
experts [19].
Materials and setting
Prototype encounter decision aids were built for a vari-
ety of clinical scenarios, including 21 decisions concern-
ing antithrombotic therapy and one for cancer treatment 
[20, 21]. The choice of supporting evidence summaries 
was driven by the fact that several authors had con-
ducted extensive GRADE evidence summaries related to 
an update of the American College of Chest Physicians 
Evidence-Based Clinical Practice Guidelines on the top-
ics [20]. Antithrombotic therapy decisions addressed new 
oral anticoagulants (for pulmonary embolisms, deep vein 
thrombosis and atrial fibrillation) and thromboprophy-
laxis during pregnancy. We used GRADE evidence 
summaries published in digitally structured formats in 
MAGICapp [4, 5]. The cancer scenario addressed adju-
vant tamoxifen treatment to prevent recurrence of breast 
cancer; we produced a GRADE evidence summary based 
on trial results [15]. All decision aids reflected decisions 
deemed particularly sensitive to patient values and pref-
erences, typically accompanying weak recommendations 
according to the GRADE framework [22]. The decision 
aids were available in English and Norwegian.
The completed Standards for Reporting Qualitative 
Research checklist is included as Additional file 1.
Participants and recruitment
We performed user-testing of the decision aids in real-
life consultations in secondary and tertiary health care 
facilities in Norway (Innlandet Hospital Trust, Gjø-
vik and Oslo University Hospital, Oslo), the United 
Kingdom (Ninewells Hospital, Dundee) and Canada 
Fig. 1 Generation of SHARE-IT encounter decision aids through the MAGICapp authoring and publication platform
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(McMaster University Hospital and Hamilton General 
hospital, Ontario). A convenience sample of physicians 
was recruited, with variable experience in risk com-
munication and variable familiarity of the clinical topic. 
Patients were recruited through the participating phy-
sicians as part of either their outpatient clinic visits or 
acute hospital inpatient admissions.
Data collection
A team member provided a brief demonstration of the 
tool, typically less than 10 min, demonstrating to partici-
pating physicians the use of the encounter decision aid. 
A study member directly observed the clinical encoun-
ter, noting the use of the decision aids, and patients’ 
questions regarding their management. We audio-
recorded and transcribed the consultations, followed 
by professional translation to English for encounters in 
Norwegian.
Directly after the consultation, the team member who 
had observed the encounter conducted separate think-
aloud sessions with patients and clinicians. We used a 
semi-structured interview guide with questions eliciting 
feedback on their experience and on the format and usa-
bility on the decision aid. The focus of our attention was 
their actual experience. Suggestions for improvement 
were also collected. At the end of the interview respond-
ents completed the 20-item COMRADE instrument, 
which provides a quantitative assessment of risk commu-
nication and confidence in the decision [23]. COMRADE 
uses a 5-point scale from 1(strongly agree) to 5 (strongly 
disagree) [24].
Data analysis
We coded transcriptions of the audio-recordings of the 
clinical encounters and semi-structured interviews. Con-
tent analysis was performed through both deductive and 
inductive approaches, searching for units of meaning 
and condensing text [25]. We then compared and added 
codes to the results and searched for barriers, problems 
and facilitating elements or characteristics of the tool 
that influenced the user experience and the process of 
shared decision-making. Each element of meaning was 
coded using a revised version of Morville’s framework 
(Fig. 3) categorizing eight different facets of “user expe-
rience” to sort results into categories: findability, useful-
ness, usability, understandability, credibility, desirability, 
identification and accessibility [26, 27]. Finally, each ele-
ment was also coded with regards to the quality of the 
Fig. 2 Prototyping, User-testing and Implementation of SHARE-IT decision aids in the MAGICapp for their generic production
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experience—i.e., positive feedback, neutral experience, 
suggestions for improvement of the tool, minor frustra-
tion and major frustration (“show stoppers”).
Results
Development of framework and prototype encounter 
decision aids
In the three DECIDE stakeholder meetings, 22 experts 
provided extensive feedback and suggestions to inform 
the conceptual framework and prototype decision aid 
formats. Core desirable features of the decision aids 
included: (1) communicating risk and uncertainty, (2) 
navigating the content, (3) facilitating use of the encoun-
ter decision aids both within and outside the clinical 
encounter, and (4) the inclusion of burden of treatment/
practical issues. Following several iterations, the experts 
reached consensus on a prototype decision aid ready to 
undergo user-testing (Figs. 4, 5).
Iterative development through user testing
We performed four major iterations of the decision aid 
presentation formats, based on the observations and 
analyses of 28 real-life consultations with physicians and 
patients (median age 53, range 19–90, 64% women). Par-
ticipants used tablet computers (e.g., iPads) in 47% of 
the consultations, desktop or laptop computers in the 
remainder. COMRADE response rate was 72.7% (n = 20). 
Patients rated both items of risk communication and 
items in their confidence in the decision with a median of 
1 on the 5-point scale (i.e. “strongly agree”).
Overview of user‑experiences
Table  1 provides a quantitative summary of user-expe-
riences with the encounter decision aids categorized 
according to the revised Morville’s facets (Fig. 3) and the 
quality of the experience coded as: positive feedback, 
neutral experience, suggestions for improvement, minor 
frustration and major frustration. These were based on 
content analysis of transcripts of the consultations and 
semi-structured interviews. Elements of major or minor 
frustration, with or without suggestions for improve-
ment, were the main drive for improvement of the tool 
across iterations, as they affected most the user experi-
ence. Neutral experience referred to statements voiced 
by users, which were neither positive nor negative, that 
provided insight on how they navigated across the differ-
ent features or functionalities of the tool. Together with 
spontaneous positive feedback, they pointed at function-
alities of the tools that worked smoothly in the course of 
the clinical encounter.
We coded 586 observed units of meaning across all 
interactions. Most reported issues involved understand-
ability and usefulness, whereas findability and credibility 
aspects were least reported. Regarding the quality of the 
experience, there were no showstoppers. The majority of 
observations (43%) related to ways to use the tool in con-
sultations, while 32% were expressions of positive feed-
back (e.g. praise, elements of delighted surprise), and 12% 
suggestions for improvement. We provide below a syn-
thesis of the findings in each of the facets, with illustrative 
quotes directly from the consultations and interviews.
Accessibility
Across iterations, the majority of comments concerned 
the readability, font colours or size, or visual contrast (e.g. 
they needed to put on their glasses) with other expres-
sions of aesthetic preferences. Patients perceived the 
tools worked well for themselves, but speculated on how 
it may not be as accessible for others, such as colour-
blind people, or older patients who may be more averse 
to technology:
57-year-old man with venous pulmonary embolism: 
“If you were using this tool with other people, other 
than me, just people 65/70 years old and afraid 
of the new technology, the picture would be a little 
blurred.”
46-year-old woman with breast cancer: “Being faced 
with an iPad or a laptop may put off some older 
Fig. 3 Modified Morville’s model for testing the experience of users
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women”
Usability
The majority of users, both clinicians and patients, 
reported that the tool was easy and simple to use with-
out need for explanation, with a design that supported 
usability.
Clinician: “Actually, it’s quite self-explanatory, 
really, the whole app.”
Clinician: “Everything was presented in a very neu-
tral way. That is, no scary fonts, no green or red 
colours that might imply certain values. I felt every-
thing was easy to read and interpret”
Physicians integrated the tool in their work-flow and con-
versations using expressions such as “let’s go back and 
see”, pointing at outcomes on the screen, asking what the 
patient wanted to look at first or leaving the direction of 
the conversation to the patient. Several did this together 
with the patient, describing the numbers, using the 
tablet together and the tool engaged both patients and 
clinicians:
Clinician: “So what do you think we should do with, 
what’s most important for you do you think, when to 
choose a medicine?”
Clinician: “Do you want to talk about the risk of 
bleeding first or the risk of clotting first or the practi-
cal considerations?”
Two clinicians commented that it took some time to get 
used to the tool and get it fully integrated in their con-
sultation, or struggling with finding the appropriate 
language:
Clinician: “Quite honestly, I felt a bit awkward using 
the tool, but it was my first time using it. Like any 
new tool, I am sure it takes practice to make it flow 
smoother.”
Clinician: “I thought the tool was a great idea. It 
was a little harder to come up with the language 
to use to discuss it with the patient than I had 
Fig. 4 Example of encounters decision aids; a first layer displaying outcomes and practical issues relevant to a given decision; b underlying layer for 
the exploration of practical issues
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expected, but in general, I thought it worked well.”
Understandability
Patients and clinicians used their own vocabulary to 
express how they understood how the tool could help 
them individualise the conversation related to risks, 
value elicitation and uncertainty in decision-making.
Clinician: This tool is supposed to help me explain, 
to compare the two [options] to help you decide 
what you would like to do at this point.”
Clinician: “We can reduce that number by 58 peo-
ple [per 1000] if we give Rivaroxaban. So there 
is some value about taking it but there are some 
downsides. Now what’s the downside you are wor-
rying about most?”
Visualisation of the evidence in the tool was informative, 
clear and easy to understand for most participants, while 
one patient reported that the pictographs were confusing:
76-year-old man with venous thromboembolism: 
“I liked the way it was presented […] both numbers 
and figures were easy to understand”
33-year-old pregnant patient with increased risk of 
venous thromboembolism: “Confusing looking at the 
board with figures [i.e. pictographs]”
All consultations contained discussion about absolute 
risks of different outcomes. This part of the conversation 
using the tool was mostly led by the clinician. There was a 
broad variability in how clinicians and patients rephrased 
the risk estimates (e.g. “small” or “high” and also applying 
it to the specific patients’ situation, particularly when less 
applicable:
Fig. 4 continued
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Clinician: “I wish I had data to say: okay if we had 
1000 guys who rode a motorcycle all the time, what’s 
the risk. I don’t have that, and I will never be able to 
get that.”
Clinician: “I am not going to tell you can’t play but 
I’m going to tell you, you have to be comfortable with 
carrying that risk. I don’t want you to play [sport] 
scared right. You know, the other thing we talked 
about briefly is what happens if you bleed on Rivar-
oxaban, you know if somebody jabbed you or some-
thing you are going to bruise up.”
In the first iteration of the decision aid prototype, the 
certainty of the evidence was labelled as “confidence” 
without any further information.
33-year-old pregnant patient with increased risk 
of venous thromboembolism giving feedback on the 
decision aid: “The box where it said something about 
confidence in the results, it said low or high. It could 
explain if it was the medical confidence in the results 
or the users’ confidence in the results.”
We then systematically incorporated in later iterations 
the main reason for the degree of certainty, taken from 
GRADE summary of findings. Most clinicians still often 
ignored certainty, except in specific conversations dis-
cussing mortality when faced with uncertainty, as they 
perceived patients would struggle to understand it:
Clinician: “I am not quite convinced that “uncer-
tainty” is a concept that patients can grasp or that 
the way it is presented in the tool is all that help-
ful.”
Clinician: “I did appreciate having the quality of 
the evidence accessible as well. Though I don’t recall 
using this feature more than one or two times in the 
encounter, it was nice to know that it was there.”
¾Users reported that medical abbreviations were not 
understandable, and the generic drug names needed 
explanation.
Clinician: “The only thing maybe ... one must always 
explain this with VTE, which is abbreviated.”
Fig. 5 Example of encounter decision aids; a Second layer comparing outcome cards; b third layer for further discussion of absolute risks and 
certainty
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Usefulness
The majority of patients and physicians perceived that 
the tool was useful and supported better information, 
value clarification and shared decision-making. They 
felt the tool contributed to reaching a decision together, 
although some highlighted decision aids were not neces-
sary to achieve a good consultation.
Clinician: “The patient thought that the tool made 
the benefits of her decision to continue taking tamox-
ifen the 10 years clearer; she had been told there was 
Fig. 5 continued
Table 1 Quantitative summary of facets of user-experiences and the quality of the experience using the decision aid







Minor frustrations Major frustrations Total
Accessibility 3 1 16 20 2 42
Credibility 1 6 1 – 8
Desirability 11 30 9 4 – 54
Findability – – 1 – – 1
Identification 29 2 1 – – 32
Understandability 126 34 11 11 6 188
Usability 43 33 14 26 2 118
Usefulness 40 81 17 5 143
Total 253 187 70 66 10 586
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a benefit but did not know how much of a benefit 
before today.”
After several consultations, both physicians and patients 
noted that they had been somehow surprised by the deci-
sion made. It allowed the presentation of useful informa-
tion that would otherwise not have been brought up in 
the conversation:
73-year-oild man with venous thromboembolism: 
“Yes, if the tool wasn’t used, I would probably not 
have gotten the information.”
Clinician: “Surprisingly, the patient ended up choos-
ing to stop medication after 3 months, congruent 
with his values. [It] probably wouldn’t have been the 
mother’s or father’s decision. [They] would have pre-
ferred that he stopped basketball for this health”.
Clinician: “At the time of consent, we were convinced 
using the tool wouldn’t change anything. After the 
consultation, we thought it was really useful to look 
at the evidence, in particular graphically.”
Another key observation related to the use of the tool, 
particularly with tablet computers, was that physicians 
and patients shifted posture from sitting across each 
other to side-by-side, looking at the tablet, and even 
holding it together when having a conversation.
64-year-old man with venous thromboembolism 
reflecting on the use of the decision aid: “It shown 
you graphs […] rather than just sitting back verbally 
across the desk and saying… like Dr. X did.”
The simplicity of the various presentation formats, allow-
ing an overview, the comparison of benefits and harms, 
and the exploration of the same information in different 
formats, both visually and numerically, was highlighted 
as particularly useful:
52-year-old woman with breast cancer giving feed-
back on the decision aid: “The simplicity of it is actu-
ally one of its strengths I think”
64-year-old man with venous thromboembolism 
reflecting on the use of the decision aid: “I think a 
picture says 1000 words […] it’s giving you the stats, 
it’s also showing you stats. […] I think for many peo-
ple it’s easier to understand that when you see the 
graph than just to hear it and just see a number.”
Users appreciated the possibility to easily compare and 
switch between different clinical outcomes, supporting 
the natural flow of the conversation rather than following 
a pre-defined pathway:
52-year-old woman with breast cancer giving feed-
back on the decision aid: “The most helpful feature 
is the flexibility - being able to switch between dif-
ferent clinical outcomes for any given clinical sce-
nario. […] I like the fact that you can bring them 
up side-by-side as well, I think that’s really helpful 
rather than kind of exiting and entering, you know, 
and trying to remember the ones from before.”
Clinician: “If the conversation shifts in a particu-
lar direction, e.g., the patient wants to talk more 
about bleeding, we can shift the tool in that direc-
tion. I really appreciated this flexibility, because it 
made my discussion more responsive and natural.”
Views around the overall amount of information avail-
able or displayed were highly variable:
53-year-old woman with venous thromboembo-
lism reflecting on the content of the decision aid: 
“A lot of information. Should not be less but is dif-
ficult to grasp all of it.”
71-year-old man with venous thromboembolism 
reflecting on the content of the decision aid: Patient 
15 (VTE): “No superfluous information. Very short 
and concise so rather have some more details.”
Decision aids varied in the total number of outcomes 
that they included (i.e. up to 10 outcomes), which led to 
variable feedback on their optimal number or the order 
in which they may be presented at the top level of the 
tool, although users also recognized the value of choos-
ing which one to focus on in the clinical conversation:
Clinician: “Actually, [the outcomes] are lost, the 
really important ones […] perhaps a bit over-
whelming.”
Clinician: “I was going to say if there’s a way of 
having the ones that are actually more relevant, 
but the point is that it’s what the patient thinks is 
relevant isn’t it?”
This issue led us to develop an authoring feature in 
MAGICapp that allows the selection of which out-
comes of the GRADE summary of findings table to 
display in the decision aids, and the possibility of rela-
belling the outcomes (Table 2).
Finally, several patients highlighted that it would be 
useful to have written information to bring home to be 
able to remember the content of the conversation and 
to discuss with close ones:
47-year-old man with venous thromboembolism: 
“So, something that complements this that you can 
look on your own, at home, that’s interesting. And 
spend a little extra time looking at it. Because you 
know, I’m going to go home, and my wife is going to 
ask me 100 questions.”
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This issue led to the development of a printable version of 
the decision aid (Table 2).
Identification
The patients identified with the content and felt the tool 
was about their own choice. Physicians used the tool 
to enhance awareness of choices or to find out what 
mattered most, for example steering the conversation 
towards the daily life implications for patients:
90-year-old woman with venous thromboembolism: 
“So I just need to be careful not to prick myself with 
the needle when I’m sewing”
Some patients felt that the physicians’ knowledge was 
more relevant to their own decision than what was pre-
sented in the tool. Clinicians also spontaneously clarified 
when the patient’s risk might differ from what is shown:
Clinician: Now this data, this stuff that we con-
structed from big studies, but this is a little different 
from you.”
Credibility
Both the physicians and patients perceived the tool 
as trustworthy, both in content and the way it was 
presented:
47-year-old man with venous thromboembolism 
reflecting on the decision aid: “I feel confident I saw 
all important information to take a decision”
Clinician: “The order was correct: why you take the 
medication, what prevents it, the most important 
complications”
Desirability
Many clinicians and patients expressed a preference in 
having the tool used in a consultation, rather than not, 
and one patient thought that the tool would empower 
patients.
74-year-old man with venous thromboembolism 
reflecting on the use of the decision aid: “I feel a bit 
privileged coming here, cause other patients that 
go to their GP might not get the same introduction”
Clinician: “I think that a problem with many of 
these sorts of decision aids they just get too com-
plicated, so I think this is quite nice” … “I think 
it’s great, I, I’d like to be able to use it in the clinic 
actually, because I think it’s quite, quite a helpful 
way of practically explaining things to people with, 
with some detail, but not too much detail”
Table 2 User-testing findings of barriers and issues and solutions to inform iterations of the encounter decision aids
Barriers and issues discovered during the user testing Changes in the subsequent iterations
Accessibility Lack of contrast in text and pictographs
Scrolling was needed to see all content when tablet was verti-
cal
Wi-Fi issues in hospitals
Enhanced contrasts, changed colours
Scrolling removed
Created off-line version and print version
Usability Suggestion of a top layer to ease the introduction to the tool
Difficulty coming up with language to use the tool
Suggestion to combine the tool with information provided to 
patient before encounter
Suggestion to have the possibility to change the denominator 
in the icons (and possibly in the numbers)
Supportive sentence “What aspect would you like to discuss next? 
Choose and compare” outcomes to raise choice awareness
Possibility to change data entry and display directly in MAGICapp 
feeding in the interactive decision aid content
Understandability Concept of certainty
Medical abbreviations difficult to understand
Generic drugs names confusing
Main reason for uncertainty made available one click away
Names and descriptions of outcomes can be edited
Usefulness Great variability in the perception of the appropriate amount of 
information, in particular the number and order of outcomes
Useful to have something to bring home
Suggestion of a feature that could compare several options
Number of outcomes and their order can be selected indepen-
dently of underlying evidence profile
Print version developed
Multiple comparisons prototype in development
Identification The patient’s risk might be different from what is shown in the 
tool
Highlight during demonstration and in quick educational mod-
ules that this is encounter decision aid to be used together with 
a clinician, who can adapt content to each patient, highlighting 
potential similarities or differences
Credibility Different colour of outcome card for practical issues could lead 
to selection bias
Specific design developed to display practical issues and navigate 
across them [12]
Findability Clinician needed more information on evidence behind esti-
mates in decision aids
Integration with MAGICapp with decision aids directly linked to 
GRADE evidence summaries
Page 12 of 15Heen et al. BMC Med Inform Decis Mak          (2021) 21:202 
Findability
Since the decision aid was directly provided for each 
encounter, we were unable to explore issues related to 
how challenging it would be to find it during an encoun-
ter. The only aspect that came up related to physicians’ 
needs to have easy access to the supporting evidence 
for the estimates-effect provided in the decision aid. 
This issue was solved by the integration of decision aids 
in MAGICapp where all underlying evidence is directly 
linked to the decision aid (Table 3).
Changes made in presentation formats across iterations 
of the prototype
We performed four major iterations of the decision aid 
presentation formats based on user-experiences. Table 2 
summarizes the identified issues and barriers followed 
by specific solutions that were implemented across 
iterations. Final versions of the generic decision aids 
were reached after the team reached consensus that the 
decision aid prototype successfully involved patients 
in shared decision-making and satisfied the needs of 
patients and physicians.
A final version of the generic decision aids was reached 
and read for integration in an authoring and publication 
platform for their generic and semi-automated creation. 
Table  3 summarized the main features in the decision 
aids.
Integration in MagicApp
We integrated the prototype in MAGICapp (Figs.  4, 
5) The technical integration of the final version of the 
decision aid prototype specifically resulted in a: (1) 
automatically generated decision aids for all available 
GRADE evidence summaries linked to recommenda-
tions in the platform, (2) access to all underlying evi-
dence, (3) automatic update of decision aids when the 
evidence summary is updated and (4) selecting the 
number of displayed outcomes and changing labels for 
more lay language wording whenever relevant.
MAGICapp has numerous (> 1000) available deci-
sion aids. Since users and customers of the platform 
are responsible for producing the evidence summary 
and own it, we have not performed a formal quality 
assurance of accuracy and clinical relevance of all avail-
able decision aids. The integration in MAGICapp also 
makes it possible to easily generate widgets so the deci-
sion aids can be integrated on other online platforms 
(e.g. button links to decision aids from the BMJ Rapid 
Recommendations.)
Discussion
We have developed encounter decision aids linked to 
evidence summaries that have informed trustworthy 
guidelines to facilitate shared decision-making with 
patients at the point of care. User-testing in real clini-
cal encounters revealed opportunities for improvement 
in readability, understandability, usability and informa-
tion overload that we addressed through four design 
iterations. After addressing these issues, user-testing 
demonstrated that the developed decision aids are 
understandable and intuitive; support conversation on 
issues that matter most to patients; and help clinicians 
share evidence regarding benefits, harms, their associ-
ated degree of certainty, along with practical issues rel-
evant to each management option.
Table 3 Main concepts and features of the decision aids
- Electronic generic framework for decision aids integrated in an authoring and publication platform for guidelines and evidence summaries (MAGI-
Capp)
- Decision aids are semi-automatically produced and updated based on content in MAGICapp with adaptation possibilities (e.g. wording and number 
of outcomes, language)
- Multi-layered presentation format:
 ○ First layer displays the list of patient-important outcomes and practical issues (Fig. 4a)
 ○ Second layer displays interactive outcome cards with evidence estimates, certainty, and patient-important practical issues across 15 generic catego-
ries. Possibility to interactively compare two or more outcomes in parallel (Fig. 5a)
 ○ Third layer displays a corresponding set of pictographs showing the absolute risk with each option (Fig. 5b) and practical issues related to the treat-
ment option (Fig. 4b)
- Educational module developed http:// magic proje ct. org/ 161128/ and integrated in MAGICapp. Content was generated to mimic the very short dem-
onstration used during user-testing
- Print functionality of decision aids create pdf files that can be printed or used for notetaking and/or to bring home
- Prototype for comparisons between multiple options are developed and implemented in a BMJ Rapid Recommendation [28]
- Offline feature so decision aids can be used without use of Internet
- Widgets from MAGICapp to grab and show a given decision aid on any other online platform Example: Rapid Recommendation on Prostate cancer 
screening (https:// www. bmj. com/ conte nt/ 362/ bmj. k3581 to BMJ infographic) which links to MAGICapp content, including widgets to decision aids 
for various profile of patients
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Strengths and limitations
Strengths of our project include the user-testing of the 
decision aids in real-life consultations and in a variety 
of clinical settings. Suggestions for improvements from 
users resulted in changes that produced a higher degree 
of usability and accessibility.
The brief introduction to the tool proved sufficient that 
clinicians and patients described it as easy to use and 
understand.
A key element is the perceived trustworthiness of the 
content, which was captured by the user experience 
dimensions of credibility and identification. Clinicians 
also outlined their need to link back to the detailed evi-
dence summary and sources of uncertainty, which the 
tool provides.
In regard to limitations, our study may have selected 
clinicians who were more versed in, and more enthusias-
tic about innovative approaches for risk communication. 
Moreover, the current study focused only on situations 
in which patients face two management alternatives and 
did not explore decision aids for multiple comparisons. 
Development a tool dealing with multiple options is in 
progress, and is currently included in recent BMJ Rapid 
Recommendations, for example on screening for colorec-
tal cancer [28].
Shared decision-making hinges on clinicians having 
access to up-to-date and quality appraised evidence [29]. 
This was achieved by integrating the framework in MAG-
ICapp to semi-automatically produce decision aids based 
on content from guidelines and evidence summaries. 
This, however, requires someone to carry out the updat-
ing process, which remains a hit-or-miss phenomenon.
User-testing was performed before mandatory social-
distancing required by COVID-19 restrictions. General-
izability to virtual consultations remains to be confirmed, 
although the online nature of the tool allows its use from 
afar.
Implications for encounter decision aid production
Information overload is a critical challenge in the devel-
opment of evidence-based tools. This is particularly true 
for decision aids, which risk excessive information that 
may compromise useful conversations. To that end, the 
design of our generic decision aids was heavily inspired 
by the work of Montori and colleagues who identified 
the need for encounter decision aids to be as “quiet” as 
possible: i.e. that the tool does not impose a necessary 
sequence of predefined algorithms of questions and 
answers, that pushes the interaction into a pre-defined 
script, but instead organizes information so as to support 
the actual conversation that occurs between clinicians 
and their patients on what matter most to them [15, 30].
We implemented a similar approach through our inter-
active multi-layered formats. User testing allowed us to 
explore those elements that were better to highlight in 
top levels and those that could be presented in deeper 
layers. The final version of the decision aids has a top 
layer displaying only the list of outcomes and practical 
issues, without any numbers. Intermediate layers pro-
vide a synoptic view of each potential benefit or harm, 
followed by deeper layers providing detailed pictographs 
and underlying information, such as reasons for uncer-
tainty in the estimates of benefits and harms.
Such information was sometimes useful and other 
times distracting. Iterative user-testing demonstrated 
that patients appreciated the flexibility of this approach, 
as well as the possibility to easily switch between differ-
ent outcomes and issues. Moreover, as the number and 
labelling of outcomes in the decision aids sometimes 
needed to differ from the supporting GRADE evidence 
summary, we implemented the functionality to edit the 
decision aids automatically generated in MAGICapp.
The multi-layered approach allows the display of more 
outcomes than static GRADE summary of findings tables 
allow (usually not more than 7 most critical and impor-
tant outcomes) [31]. In common with other encounter 
tools tested by Montori et al., patients reached most deci-
sions after exploring only a selection of outcomes (usu-
ally 3 to 4) [15, 30].
SHARE-IT represents the first successful, user-tested 
effort to fully integrate production of decision aids with 
the production and dissemination of evidence sum-
maries, recommendations and guidelines. This integra-
tion also makes it possible to adapt the content (e.g. to 
national guidelines or policies or certain populations). 
The content and quality of the decision aids are, however, 
dependent on the quality of the evidence summaries.
Education and training are also central in any imple-
mentation strategy. Use of SHARE-IT decision aids 
required minimal demonstration of the tool, as shown 
in our short online education module [32]. This was 
sufficient to explore it intuitively during a real clinical 
encounter. As piloted by several clinical educators in our 
team, example of such decision aids linked to guidelines 
can be used in rounds and bedside teaching, a strategy 
that warrants further evaluation. This may help to over-
come an important barrier: the benefits of using decision 
aids (as well as engaging in shared decision-making alto-
gether) are really known after one has experienced it.
Conclusion
Our study provides a proof of concept that encounter 
decision aids can be generically produced from GRADE 
evidence summaries or recommendations for clinical 
practice. Further evaluation is needed in more clinical 
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contexts and as part of educational and broader imple-
mentation strategies. This would require that decision 
aids are available for a large number of clinical decisions. 
The integration of SHARE-IT decision aids in MAGI-
Capp offers great potential in scaling up their production 
and continuous update along with evidence summaries 
and clinical practice guidelines.
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